Chris Hannay: Rising Demand for Immunoglobulin Driving Plasma Industry Growth in Canada
Chris Hannay, Health and Business Reporter at The Globe and Mail, shared a post on LinkedIn:
“I’ve written a few stories over the years about commercial plasma collectors coming to Canada.
But there are some numbers in the industry that I think are pretty surprising.
Here are a few.
- $1-billion: The amount Canadian Blood Services spent on plasma protein and related products last year. (This is almost two-thirds of its budget.)
- 1%: The amount of plasma collected by Canadian Blood Services that was used for transfusion. (The rest was sent to commercial partners to be processed into other pharmaceutical products, especially immunoglobulin.)
- 3: Canada is the third-highest-per-capita user of immunoglobulin in the world.
- 50%: How much demand for immunoglobulin is expected to grow over the next five years, according to Canadian Blood Services.
This huge demand for and spending on immunoglobulin has been underpinning the growth of commercial plasma collection and manufacturing in Canada in recent years.
I explain it all in a new story today that is a bit heavier than usual on numbers and charts:
Of course, whether things can continue to grow as they have is another question. I also talk to some people (Choosing Wisely Canada) working on how to use these resources most appropriately.
Thanks to Peter Jaworski (who recently launched a research group for plasma at Georgetown University) for tracking down some of the data.”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?